Edaravone combined with neural stem cell transplantation for treatment of spinal cord injury in rats

Zhao Zhi-jun,Sun Zhi-min,Zhang Chun-yang,Han Jian-guo,Shi Rui-cheng,Wang Wei-zhi
DOI: https://doi.org/10.3969/j.issn.2095-4344.2013.10.024
2013-01-01
Abstract:BACKGROUND: Edaravone is a kind of free radical scavenging drug, which can reduce the edema of the damaged nerve tissue and improve the microenvironment of spinal cord injury areas.OBJECTIVE: To observe the effects of edaravone combined with neural stem cell transplantation in the treatment of spinal cord injury in rats. METHODS: A total of 80 Sprague-Dawley rats were used to establish the T9 spinal cord transaction models, and the models were randomly divided into four groups (n=20), namely the control group, edaravone group, neural stem cells transplantation group and neural stem cell transplantation + edaravone group. The models in the control group received no treatment; models in the edaravone group were injected with edaravone via tail vein at 6 hours after spinal cord injury; models in the neural stem cell transplantation group were injected with neural stem cell suspension in the spinal cord injury area at 6 hours after spinal cord injury; models in the neural stem cell transplantation + edaravone group were injected with neural stem cells and edaravone via tail vein at 6 hours after spinal cord injury. RESULTS AND CONCLUSION: PKH-26-labeled neural stem cells survived and migrated toward the spinal cord at 8 weeks postoperatively; a small amount of continous nerve fibers migrated across the injury site in the neural stem cell transplantation group and neural stem cell transplantation + edaravone group. Fluorogold retrograde spinal cord tracing showed the fluorogold-labeled pyramidal cells migrated across the injury site in the neural stem cell transplantation group and neural stem cell transplantation + edaravone group. The number of fluorogold- labeled nerve fibers and PKH-26 positive cells was largest in the neural stem cell transplantation + edaravone group, greater in the edaravone group but little in the control group, and there was significant difference between groups (P<0.05). The BBB scores of the hind limb motor function: neural stem cells transplantation + edaravone group>neural stem cell transplantation group>edaravone group>control group. Edaravone can promote the survival of neural stem cells and their differentiation into neural cells at the injury site. Edaravone combined with neural stem cell transplantation can promote the repair of spinal cord injury in rats.
What problem does this paper attempt to address?